Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019

Canada NewsWire July 15, 2019

Valens to Commence Trading on the TSX Venture Exchange

Canada NewsWire July 8, 2019

Horizons ETFs Rebalances Marijuana-Focused ETFs

Canada NewsWire July 3, 2019

Valens substantially increases annual extraction capacity to 425,000KG with plans to increase capacity to over 1,000,000KG

Canada NewsWire June 18, 2019

Valens Receives Conditional Listing Approval on TSXV and Accelerates Q2 Filing Date

Canada NewsWire June 17, 2019

Valens Expands Size and Scope of Agreement With Tilray

Canada NewsWire June 10, 2019

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Canada NewsWire June 6, 2019

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Canada NewsWire May 31, 2019

Valens signs multi-year cannabis extraction agreement with Tantalus Labs

Canada NewsWire May 28, 2019

Valens Appoints President Focused on Growth Opportunities

Canada NewsWire May 27, 2019

Leading International Cannabis Expert Joins Valens Board of Directors

Canada NewsWire May 13, 2019

Valens Announces Acceleration of Warrant Expiry Date

Canada NewsWire May 2, 2019

New Research Study Proves Canadians Are Turning to Cannabis for Relaxation & Wellbeing

Canada NewsWire May 1, 2019

Valens Receives Organic Certification for Cannabis Oil Production

Canada NewsWire April 29, 2019

Valens Signs Multi-year Cannabis and Hemp Extraction agreement with HEXO Corp.

Canada NewsWire April 25, 2019

Valens Reports Record $2.2 Million in Revenue in the First Quarter of Fiscal 2019

Canada NewsWire April 24, 2019

Valens to Hold Conference Call to Discuss Financial Results for the First Quarter of Fiscal 2019

Canada NewsWire April 22, 2019

Valens GroWorks Announces Closing of $43,125,000 Bought Deal Financing

Newsfile April 9, 2019

5 of the Largest Cannabis Extraction Companies

GlobeNewswire March 27, 2019

Valens GroWorks Announces Upsize of Previously Announced Bought Deal Equity Financing to $37.5 Million

Newsfile March 20, 2019